- Report
- January 2024
- 200 Pages
Global
From €3635EUR$4,150USD£3,155GBP
Lexiva is a brand of antiviral drug used to treat HIV and hepatitis B and C infections. It is a protease inhibitor, meaning it works by blocking the action of a specific enzyme that the virus needs to replicate. Lexiva is typically used in combination with other antiretroviral drugs to treat HIV infection. It is also used to treat chronic hepatitis B and C infections, as well as to prevent HIV infection in people who are at high risk of contracting the virus.
Lexiva is a widely used drug in the infectious diseases market, as it is effective in treating and preventing a variety of viral infections. It is also relatively well-tolerated, with few side effects.
Companies in the Lexiva market include Gilead Sciences, Bristol-Myers Squibb, Merck, and AbbVie. Show Less Read more